AAAAAA

   
Results: 1-21 |
Results: 21
INHIBITION OF CISPLATIN TOXICITY AND UPTAKE IN RENAL TUBULE EPITHELIAL-CELLS BY L-CYSTEINE
Authors: KRONING R LICHTENSTEIN AK NAGAMI GT
Citation: R. Kroning et al., INHIBITION OF CISPLATIN TOXICITY AND UPTAKE IN RENAL TUBULE EPITHELIAL-CELLS BY L-CYSTEINE, The FASEB journal, 12(4), 1998, pp. 669-669
DIFFERENTIAL INHIBITION OF CISPLATIN TOXICITY AND UPTAKE IN CULTURED S1, S3 AND DCT CELLS BY L-CYSTEINE
Authors: KRONING R LICHTENSTEIN AK NAGAMI GT
Citation: R. Kroning et al., DIFFERENTIAL INHIBITION OF CISPLATIN TOXICITY AND UPTAKE IN CULTURED S1, S3 AND DCT CELLS BY L-CYSTEINE, Journal of the American Society of Nephrology, 8, 1997, pp. 2815-2815
SUPPRESSIVE FACTOR OR FACTORS DERIVED FROM HEAD AND NECK SQUAMOUS-CELL CARCINOMA INDUCE APOPTOSIS IN ACTIVATED LYMPHOCYTES
Authors: BILLINGS KR WANG MB LICHTENSTEIN AK
Citation: Kr. Billings et al., SUPPRESSIVE FACTOR OR FACTORS DERIVED FROM HEAD AND NECK SQUAMOUS-CELL CARCINOMA INDUCE APOPTOSIS IN ACTIVATED LYMPHOCYTES, Otolaryngology and head and neck surgery, 116(4), 1997, pp. 458-465
QUANTITATIVE COMPARISON OF MULTIPLE-MYELOMA TUMOR CONTAMINATION IN BONE-MARROW HARVEST AND LEUKAPHERESIS AUTOGRAFTS
Authors: VESCIO RA HAN EJ SCHILLER GJ LEE JC WU CH CAO J SHIN J KIM A LICHTENSTEIN AK BERENSON JR
Citation: Ra. Vescio et al., QUANTITATIVE COMPARISON OF MULTIPLE-MYELOMA TUMOR CONTAMINATION IN BONE-MARROW HARVEST AND LEUKAPHERESIS AUTOGRAFTS, Bone marrow transplantation, 18(1), 1996, pp. 103-110
REGULATION OF TRANSFORMING GROWTH FACTOR-BETA-1-MEDIATED APOPTOSIS INHEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: DUFFEY DC CALCATERRA TC LICHTENSTEIN AK
Citation: Dc. Duffey et al., REGULATION OF TRANSFORMING GROWTH FACTOR-BETA-1-MEDIATED APOPTOSIS INHEAD AND NECK SQUAMOUS-CELL CARCINOMA, The Laryngoscope, 106(7), 1996, pp. 889-894
PAMIDRONATE REDUCES IL-6 PRODUCTION BY BONE-MARROW STROMA FROM MULTIPLE-MYELOMA PATIENTS
Authors: SAVAGE AD BELSON DJ VESCIO RA LICHTENSTEIN AK BERENSON JR
Citation: Ad. Savage et al., PAMIDRONATE REDUCES IL-6 PRODUCTION BY BONE-MARROW STROMA FROM MULTIPLE-MYELOMA PATIENTS, Blood, 88(10), 1996, pp. 409-409
V-H GENE USAGE IN MULTIPLE-MYELOMA - COMPLETE ABSENCE OF THE V(H)4.21(V(H)4-34) GENE
Authors: RETTIG MB VESCIO RA CAO J WU CH LEE JC HAN E DERDANIELIAN M NEWMAN R HONG C LICHTENSTEIN AK BERENSON JR
Citation: Mb. Rettig et al., V-H GENE USAGE IN MULTIPLE-MYELOMA - COMPLETE ABSENCE OF THE V(H)4.21(V(H)4-34) GENE, Blood, 87(7), 1996, pp. 2846-2852
DELETION OF GENETIC MATERIAL FROM A POLY(ADP-RIBOSE) POLYMERASE-LIKE GENE ON CHROMOSOME-13 OCCURS FREQUENTLY IN PATIENTS WITH MONOCLONAL GAMMOPATHIES
Authors: CAO J HONG CH ROSEN L VESCIO RA SMULSON M LICHTENSTEIN AK BERENSON JR
Citation: J. Cao et al., DELETION OF GENETIC MATERIAL FROM A POLY(ADP-RIBOSE) POLYMERASE-LIKE GENE ON CHROMOSOME-13 OCCURS FREQUENTLY IN PATIENTS WITH MONOCLONAL GAMMOPATHIES, Cancer epidemiology, biomarkers & prevention, 4(7), 1995, pp. 759-763
A CD10-POSITIVE SUBSET OF MALIGNANT-CELLS IS IDENTIFIED IN MULTIPLE-MYELOMA USING PCR WITH PATIENT-SPECIFIC IMMUNOGLOBULIN GENE PRIMERS
Authors: CAO J VESCIO RA RETTIG MB HONG CH KIM A LEE JC LICHTENSTEIN AK BERENSON JR
Citation: J. Cao et al., A CD10-POSITIVE SUBSET OF MALIGNANT-CELLS IS IDENTIFIED IN MULTIPLE-MYELOMA USING PCR WITH PATIENT-SPECIFIC IMMUNOGLOBULIN GENE PRIMERS, Leukemia, 9(11), 1995, pp. 1948-1953
MYELOMA IG HEAVY-CHAIN-V REGION SEQUENCES REVEAL PRIOR ANTIGENIC SELECTION AND MARKED SOMATIC MUTATION BUT NO INTRACLONAL DIVERSITY
Authors: VESCIO RA CAO J HONG CH LEE JC WU CH DANIELIAN MD WU V NEWMAN R LICHTENSTEIN AK BERENSON JR
Citation: Ra. Vescio et al., MYELOMA IG HEAVY-CHAIN-V REGION SEQUENCES REVEAL PRIOR ANTIGENIC SELECTION AND MARKED SOMATIC MUTATION BUT NO INTRACLONAL DIVERSITY, The Journal of immunology, 155(5), 1995, pp. 2487-2497
IDENTIFICATION OF MALIGNANT-CELLS IN MULTIPLE-MYELOMA BONE-MARROW WITH IMMUNOGLOBULIN V-H GENE PROBES BY FLUORESCENT IN-SITU HYBRIDIZATION AND FLOW-CYTOMETRY
Authors: CAO J VESCIO RA HONG CH KIM A LICHTENSTEIN AK BERENSON JR
Citation: J. Cao et al., IDENTIFICATION OF MALIGNANT-CELLS IN MULTIPLE-MYELOMA BONE-MARROW WITH IMMUNOGLOBULIN V-H GENE PROBES BY FLUORESCENT IN-SITU HYBRIDIZATION AND FLOW-CYTOMETRY, The Journal of clinical investigation, 95(3), 1995, pp. 964-972
QUANTITATIVE COMPARISON OF MULTIPLE-MYELOMA TUMOR CONTAMINATION IN BONE-MARROW HARVEST AND LEUKAPHERESES AUTOGRAFTS
Authors: VESCIO RA HAN EJ LEE JC WU CH CAO J SHIN J SCHILLER GJ RETTIG MB LICHTENSTEIN AK BERENSON JR
Citation: Ra. Vescio et al., QUANTITATIVE COMPARISON OF MULTIPLE-MYELOMA TUMOR CONTAMINATION IN BONE-MARROW HARVEST AND LEUKAPHERESES AUTOGRAFTS, Blood, 86(10), 1995, pp. 924-924
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN PATIENTS WITH MULTIPLE-MYELOMA (MM) DOES NOT INCREASE TUMOR CONTAMINATION
Authors: HAN EJ VESCIO RA RETTIG MB CAO J WU CH LEE JC ROSEN L SCHILLER G LICHTENSTEIN AK BERENSON JR
Citation: Ej. Han et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN PATIENTS WITH MULTIPLE-MYELOMA (MM) DOES NOT INCREASE TUMOR CONTAMINATION, Blood, 86(10), 1995, pp. 1593-1593
THE CD10 ANTIGEN IS EXPRESSED ON A SUBPOPULATION OF MALIGNANT-CELLS IN ALL PATIENTS WITH MULTIPLE-MYELOMA
Authors: CAO J VESCIO RA KIM A HONG CH LEE C LICHTENSTEIN AK BERENSON JR
Citation: J. Cao et al., THE CD10 ANTIGEN IS EXPRESSED ON A SUBPOPULATION OF MALIGNANT-CELLS IN ALL PATIENTS WITH MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000171-10000171
CD38 IS EXPRESSED ON MOST BUT NOT ALL MALIGNANT-CELLS IN MULTIPLE-MYELOMA
Authors: KIM A VESCIO RA CAO J HONG CH RETTIG M VOVAN T LICHTENSTEIN AK BERENSON JR
Citation: A. Kim et al., CD38 IS EXPRESSED ON MOST BUT NOT ALL MALIGNANT-CELLS IN MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000656-10000656
THE HEMATOPOIETIC STEM-CELL ANTIGEN, CD34, IS NOT EXPRESSED ON THE MALIGNANT-CELLS IN MULTIPLE-MYELOMA
Authors: VESCIO RA HONG CH CAO J KIM A SCHILLER GJ LICHTENSTEIN AK BERENSON RJ BERENSON JR
Citation: Ra. Vescio et al., THE HEMATOPOIETIC STEM-CELL ANTIGEN, CD34, IS NOT EXPRESSED ON THE MALIGNANT-CELLS IN MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 3283-3290
IDENTIFICATION OF MALIGNANT-CELLS IN MULTIPLE-MYELOMA BONE-MARROW WITH IMMUNOGLOBULIN VH GENE PROBES BY FLUORESCENT IN-SITU HYBRIDIZATION AND FLOW-CYTOMETRY
Authors: CAO J VESCIO R HONG C KIM A LICHTENSTEIN AK BERENSON JR
Citation: J. Cao et al., IDENTIFICATION OF MALIGNANT-CELLS IN MULTIPLE-MYELOMA BONE-MARROW WITH IMMUNOGLOBULIN VH GENE PROBES BY FLUORESCENT IN-SITU HYBRIDIZATION AND FLOW-CYTOMETRY, Blood, 82(10), 1993, pp. 10000248-10000248
THE CDR3 REGIONS OF MULTIPLE-MYELOMA PATIENTS REVEAL CHARACTERISTICS SEEN IN FETAL LYMPHOID DEVELOPMENT
Authors: KUNKEL LA VESCIO R CAO J SCHILLER CJ LICHTENSTEIN AK BERENSON JR
Citation: La. Kunkel et al., THE CDR3 REGIONS OF MULTIPLE-MYELOMA PATIENTS REVEAL CHARACTERISTICS SEEN IN FETAL LYMPHOID DEVELOPMENT, Blood, 82(10), 1993, pp. 10000259-10000259
SOMATIC HYPERMUTATION OF VH GENES IN MULTIPLE-MYELOMA IS UNACCOMPANIED BY INTRACLONAL DIVERSITY
Authors: VESCIO RA CAO J HONG CH NEWMAN R LICHTENSTEIN AK BERENSON JR
Citation: Ra. Vescio et al., SOMATIC HYPERMUTATION OF VH GENES IN MULTIPLE-MYELOMA IS UNACCOMPANIED BY INTRACLONAL DIVERSITY, Blood, 82(10), 1993, pp. 10000259-10000259
MULTIPLE-MYELOMA CLONES ARE DERIVED FROM POST-CLASS SWITCH PRECURSOR CELLS
Authors: VESCIO R HONG CH CAO J LEE C DERDANIELIAN M LICHTENSTEIN AK BERENSON JR
Citation: R. Vescio et al., MULTIPLE-MYELOMA CLONES ARE DERIVED FROM POST-CLASS SWITCH PRECURSOR CELLS, Blood, 82(10), 1993, pp. 10000259-10000259
CYTOKINE PRODUCTION BY BONE-MARROW STROMA FROM PATIENTS WITH MYELOMA
Authors: KIM A VESCIO R LEE C LICHTENSTEIN AK BERENSON JR
Citation: A. Kim et al., CYTOKINE PRODUCTION BY BONE-MARROW STROMA FROM PATIENTS WITH MYELOMA, Blood, 82(10), 1993, pp. 10000569-10000569
Risultati: 1-21 |